Interview: Pierre Gabriel Côté – CEO, Investissement Québec

Investissement Québec (IQ) contributed to the completion of 65 international projects in 2017 and hosts Pfizer, Sanofi, and Merck amongst over 160 IT companies, employing over 5,400 workers. Pierre Gabriel Côté, CEO of IQ, took the reins in January 2015 and intends to digitize the investment space using Artificial Intelligence (AI) and practical applications for new technologies in manufacturing. Pierre also discusses AI's overlap with pharmaceuticals and the innovative environment at IQ that has been decades in the making. Can you please provide us with a brief overview of the historical factors that have led to Quebec to becoming such a competitive place for innovation and business, especially within the healthcare industry?
"What IQ does is what we ask our customers to do: innovate, digitize, be ready for disruptor technology and futureproof oneself."
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In

Related Interviews

Latest Report